About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02616705

Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis

Immunoglobulin G4-related disease (IgG4-RD) is an uncommon inflammatory disorder that may affect multiple organ systems, including the biliary tree. IgG4-sclerosing cholangitis (IgG4-SC) can be diffic...

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators

Nagoya University

This study will recruit cases from Mayo Clinic Rochester and Japanese institutions such as Nagoya City University Hospital, Nagoya Daini Red Cross Hospital, and Kurashiki Central hospital. Participants will be individuals who will receive endoscopic retrograde cholangiography (ERC), endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) or percutaneous transhepatic cholangiography (PTC). Bile samples collected from the target cases will be assayed for IgG4 concentration.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•The presence of a biliary stricture
•18 years and older
•Consented to IRB 707-03

Exclusion Criteria

•Younger than 18 years of age
•Unable to collect a bile sample
•Abnormal postsurgical anatomy preventing collection of a bile sample

Related studies

Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis

NCT07536841 · Autoimmune Pancreatitis, IgG4-Related Diseases, and more

RECRUITINGPhase 2

A Study of Efgartigimod in Patients With IgG4-Related Disease

NCT07025330 · IgG4-related Disease

RECRUITINGPhase 1

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647 · Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), and more

Short-term Glucocorticoid Combined with MMF for IgG4-RD

NCT06663618 · IgG4-related Disease

RECRUITINGEARLY Phase 1

Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease

NCT06497361 · Lupus Nephritis, IgG4-related Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 5, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment511

Start dateNov 2015

Last updatedJan 5, 2022

Condition

IgG4-related Sclerosing Cholangitis IgG4-related Disease

Locations shown

Mayo Clinic

Rochester, Minnesota

Nagoya City Universty Graduate School of Medical Sciences

Nagoya

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 5, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions